Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05514444
Title Study of MK-4464 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced/Metastatic Solid Tumors (MK-4464-001)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Merck Sharp & Dohme LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | CAN

Facility Status City State Zip Country Details
The University of Louisville, James Graham Brown Cancer Center ( Site 0100) RECRUITING Louisville Kentucky 40245 United States Details
Princess Margaret Cancer Centre-Division of Medical Oncology and Hematology ( Site 0201) RECRUITING Toronto Ontario M5G 2M9 Canada Details
Rambam Health Care Campus-Oncology Division ( Site 0300) RECRUITING Haifa 3109601 Israel Details
Hadassah Medical Center-Oncology ( Site 0302) RECRUITING Jerusalem 9112001 Israel Details
Nederlands Kanker Instituut - Antoni van Leeuwenhoek (NKI-AVL) ( Site 0401) RECRUITING Amsterdam Noord-Holland 1066CX Netherlands Details
Amsterdam UMC, locatie VUmc ( Site 0400) RECRUITING Amsterdam Noord-Holland 1081HV Netherlands Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field